The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of lanreotide as a therapy for pheochromocytomas (PCs) and paragangliomas (PGs).
 
Bahar Laderian
No Relationships to Disclose
 
Mengxi Zhou
No Relationships to Disclose
 
Lyndon Luk
No Relationships to Disclose
 
Susan Bates
Honoraria - Daiichi Sankyo/UCB Japan
Consulting or Advisory Role - Acrivon Therapeutics; Astellas Pharma (I); ElmediX; Pegascy
Research Funding - Ipsen (Inst); Pfizer (Inst); RenovoRx (Inst); Sun Biopharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending: METHODS FOR TREATING PANCREATIC CANCER WITH A COMBINATION OF ROMIDEPSIN AND DES-METHYL PATEAMINE A; Patent: Deacetylase Inhibitor Therapy (Inst); Patent: Depsipeptide for Therapy of Kidney Cancer (Inst)
 
Antonio Fojo
Honoraria - Daiichi Sankyo
Consulting or Advisory Role - Acrivon Therapeutics (I); Acrivon Therapeutics (I); Astellas Pharma; ElmediX (I); PEGASCY (I)
Research Funding - Ipsen (Inst); Pfizer (Inst); RenovoRx (I); Sun Biopharma (Inst)
Patents, Royalties, Other Intellectual Property - "METHODS FOR TREATING PANCREATIC CANCER WITH A COMBINATION OF ROMIDEPSIN AND DES-METHYL PATEAMINE A" (I)
 
Jaydira Del Rivero
No Relationships to Disclose